Health CanadaGeneral Alert
Remdesivir authorized with conditions for the treatment of patients in Canada wi...
Published: July 28, 2020Recall ID: 61492Category: generalCountry: Canada
Reason for Recall / Hazard
COVID
Product Description & Identification
Remdesivir authorized with conditions for the treatment of patients in Canada with severe COVID-19 symptoms
Additional Source Details
| Field | Value |
|---|---|
| N I D | 61492 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/remdesivir-authorized-conditions-treatment-patients-canada-severe-covid-19-symptoms |
| Issue | COVID |
| Title | Remdesivir authorized with conditions for the treatment of patients in Canada with severe COVID-19 symptoms |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2020-07-28 |
| Organization | Communications and Public Affairs Branch |